Definium Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| DRIEHAUS CAPITAL MANAGEMENT LLC | 02/17/2026 | 6.54 M | $87.53 M | 100.00% | 7.32% |
| MARSHALL WACE, LLP | 02/13/2026 | 2.98 M | $39.84 M | 100.00% | 3.33% |
| AWM INVESTMENT COMPANY, INC. | 02/13/2026 | 1.39 M | $18.62 M | 100.00% | 1.56% |
| ENSIGN PEAK ADVISORS, INC | 02/12/2026 | 262.00 K | $3.51 M | 100.00% | 0.29% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 52.23 K | $700.00 K | 100.00% | 0.06% |
| DARK FOREST CAPITAL MANAGEMENT LP | 02/17/2026 | 30.66 K | $410.55 K | 100.00% | 0.03% |
| SOUND INCOME STRATEGIES, LLC | 01/21/2026 | 3.69 K | $55.54 K | 100.00% | 0.00% |
| 03/02/2026 | 391 | $6.82 K | 100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Definium Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 117 institutional investors and hedge funds held shares of Definium Therapeutics Inc.. The most heavily invested institutionals were:
Candriam S.C.A.: 1.29 M
Bank of New York Mellon Corp: 752,922
Nuveen, LLC: 698,130
VANGUARD FIDUCIARY TRUST CO: 575,937
UBS Group AG: 493,977
DEUTSCHE BANK AG\: 411,834
12.60% of Definium Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 18.14 M shares in the last 24 months. This purchase volume represents approximately $332.82 M in transactions.